# DAISe 1 Feasibility Study to Evaluate the DAISe Thrombectomy System for Acute Ischemic Stroke

> **NCT05139147** · NA · TERMINATED · sponsor: **MIVI Neuroscience, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DEVICE:** DAISe Thrombectomy System

## Key facts

- **NCT ID:** NCT05139147
- **Lead sponsor:** MIVI Neuroscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-12
- **Primary completion:** 2023-07-20
- **Final completion:** 2023-08-04
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Enrollment/Recruitment
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05139147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05139147, "DAISe 1 Feasibility Study to Evaluate the DAISe Thrombectomy System for Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05139147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*